Edward M. Kaye

2011 - Sarepta Therapeutics

In 2011, Edward M. Kaye earned a total compensation of $1.2M as Senior Vice President, Chief Medical Officer at Sarepta Therapeutics.

Compensation breakdown

Bonus$130,000
Non-Equity Incentive Plan$60,938
Option Awards$791,010
Salary$194,600
Other$9,167
Total$1,185,715

Kaye received $791K in option awards, accounting for 67% of the total pay in 2011.

Kaye also received $130K in bonus, $60.9K in non-equity incentive plan, $194.6K in salary and $9.2K in other compensation.

Rankings

In 2011, Edward M. Kaye's compensation ranked 5,040th out of 10,747 executives tracked by ExecPay. In other words, Kaye earned more than 53.1% of executives.

ClassificationRankingPercentile
All
5,040
out of 10,747
53rd
Division
Manufacturing
1,815
out of 3,960
54th
Major group
Chemicals And Allied Products
379
out of 1,033
63rd
Industry group
Drugs
235
out of 781
70th
Industry
Pharmaceutical Preparations
185
out of 571
68th
Source: SEC filing on April 30, 2013.

Kaye's colleagues

We found three more compensation records of executives who worked with Edward M. Kaye at Sarepta Therapeutics in 2011.

2011

Christopher Garabedian

Sarepta Therapeutics

Chief Executive Officer

2011

Effie Toshav

Sarepta Therapeutics

General Counsel

2011

Michael Jacobsen

Sarepta Therapeutics

Vice President, Finance

News

In-depth

You may also like